Our journals offer ESMO members and the oncology community a globally visible platform to publish scientific studies, and a highly credible source of educational updates. Discover ESMO's new social media dashboard where you will find all your favourite posts and tweets in one place! ESMO40 Celebrate with us: watch our anniversary videos, take a virtual stroll through our timeline of 'ESMO firsts' or share your wishes for the future with us….
Our research is aimed at developing new therapies for a form of breast cancer that is currently difficult to treat. This difficult-to-treat form of breast cancer is known as triple-negative breast cancer, so called as it lacks the 3 important biomarkers, ER, PR and HER2. Since patients with triple-negative breast cancers lack these 3 biomarkers, they cannot be treated with drugs such as tamoxifen or Herceptin.
Researchers confirm the poor quality of care for men affected by breast cancer and urge for a clinical trial. Brussels, 2 February — Recent findings from the International Male Breast Cancer Programme confirm that male and female breast cancers are undeniably different and that 1 out of 3 men affected by the disease is not treated optimally. They also highlight a breast cancer subtype that seems to occur only in men.
NCI-funded researchers are working to advance our understanding of how to prevent, detect, and treat breast cancer. They are also looking at how to address disparities and improve quality of life for survivors of the disease. MRI magnetic resonance imagingultrasoundand clinical breast exams are also used to detect breast cancer, but not as routine screening tools. Ongoing studies are looking at ways to enhance current breast cancer screening options.
We have extensively used the new facility over the past 5 years. The consultation rooms allow us to see patients who are participating in clinical trials. The Unit also conducts breast imaging studies within clinical trials and the facilities for biopsy and sample collection for research are vital to our efforts in finding better ways of treating breast cancer.
Researchers around the world are working to find better ways to preventdetectand treat breast cancer, and to improve the quality of life of patients and survivors. Studies continue to uncover lifestyle factors and habits, as well as inherited genes, that affect breast cancer risk. Here are a few examples:.
Research Assistant: Sabina Trebinjac Phone:ext. Pritchard is a medical oncologist and clinical trials research scientist. Her areas of interest include multicentre clinical trials; adjuvant, biologic and hormonal therapy for breast cancer; correlative and translational research in breast cancer; banking of tumour, tissue, serum and data; and predictive and prognostic factors in breast cancer.
Every Friday afternoon nearly 20 researchers at the Medical College of Wisconsin MCW — from basic scientists who work at the laboratory bench to clinician-scientists who treat patients at the bedside — gather around a conference room table for an important meeting. The meeting is supposed to last an hour, but it often stretches much longer as these faculty members excitedly share their latest research developments and ideas regarding one goal: fighting breast cancer. The collective brainpower of these individuals — MCW's Breast Cancer Biology Research Group — is paying off in the form of new collaborations and advances.
Breast cancers are the leading cancers in women with about 50, new cases per year in France. Breast cancers are composed of molecularly distinct subtypes with different clinical outcomes and responses to therapy. The efficacy of their therapeutic management has improved considerably in recent years.